Low Vaccination Rates Contributed to Spread of Measles
The measles outbreak that began at Disneyland spread because people were not vaccinated, according to a research study published in a pediatric medical journal.
The Flu Vaccine Has Been Ineffective Against a Mutating Virus
While the flu vaccine is pushed, even after side effects have become well known, it seems that it might be an unnecessary risk after all. The flu vaccine has been little help preventing new cases of the common illness this year.
Obama Praises Ebola Vaccine Testing, Calls for More Funding
As health officials have completed the first phase of testing on the Ebola vaccine the President is asking for more funding to aid in the response to the epidemic.
New Device Takes Fear Out of Influenza Vaccinations
A new machine called a jet injector will deliver the flu vaccine without the use of a needle. This may increase or decrease needle related vaccine injuries.
U.S. Court of Federal Claims to Host 27th Annual Judicial Conference
The 27th Annual U.S. Court of Federal Claims Judicial Conference will take place on Monday, November 17, 2014.
GBS/CIDP Foundation to Host 13th International Symposium
Friday, Oct. 31, 2014 – Sunday, Nov. 2, 2014 Come learn everything you need to know about GBS, CIDP and MMN from diagnosis to treatment.
Several Vaccine Choices This Flu Season
With all of the options available for receiving the flu vaccine this year, you would be best served to investigate the possible side effects associated with each before making a decision.
Autism Caused by MMR Vaccine: CDC Cover-Up Exposed by CDC Whistleblower
A CDC whistleblower, Dr. William Thompson, is claiming that the agency covered up the connection between autism and the Measles-Mumps-Rubella vaccine in boys.
Live Attenuated Influenza Vaccine [LAIV] (The Nasal Spray Flu Vaccine)
All nasal spray vaccines for the 2013-14 season will provide protection against four flu viruses: an influenza A (H1N1) virus, an influenza A (H3N2) virus and two influenza B viruses.
Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013
Since mid-2006, the Advisory Committee on Immunization Practices (ACIP) has recommended routine vaccination of adolescent girls at ages 11 or 12 years with 3 doses of human papillomavirus (HPV) vaccine (1). Two HPV vaccines are currently available in the United States. Both the quadrivalent (HPV4) and bivalent (HPV2) vaccines protect against HPV types 16 and 18, which cause 70% of cervical cancers and the majority of other HPV-associated cancers; HPV4 also protects against HPV types 6 and 11, which cause 90% of genital warts.* This report summarizes national HPV vaccination coverage levels among adolescent girls aged 13–17 years† from the 2007–2012 National Immunization Survey-Teen (NIS-Teen) and national postlicensure vaccine safety monitoring.